Newly launched radioligand company and more funding events…
Want to get this list of recently funded companies and more data? Fill out a quote request to get more info (Quote Request Form)
FIG. 1. Recent Biotech Funding Activity.
– Private Funding –
Gameto
💸 Closed $33M Series B funding led by Two Sigma Ventures with RA Capital to advance the development of Fertilo.
Adcendo
💸 Raised additional €16M Series A funding led by Dawn Biopharma to strengthen ADC assets and advance its lead uPARAP program.
ExpressionEdits
💸 Raised $13M seed funding co-led by Octopus Ventures and Redalpine to advance protein expression using AI-driven intronization technology.
Biophta
💸 Raised €6.5M seed funding to fund a first-in-human trial of breakthrough topical ophthalmic inserts.
Radiomer Therapeutics
💸 Launched with undisclosed pre-seed funding to advance radioligand therapy platform.
– Post-IPO/Public Funding –
Insmed
🏦 Announced ~$650M public offering to fund continued R&D of brensocatib and pre-commercial and, if approved, commercialization activities related to brensocatib.
Cytokinetics
🏦 Closed $500M public offering.
Merus
🏦 Announced their proposed $300M public offering and intends to use the proceeds from the offering to advance the clinical development of its product candidates, among others.
BioNano Genomics
🏦 Raised $18M in private placement to eliminate debt and advance optical genome mapping technology.
ElectroCore
🏦 Announced pricing of $9.3M direct offering to be used for sales and marketing, working capital, and general corporate purposes. ---
Article History:
RF, DV, DG (06/04/24)
This article is not investment or legal advice.
Comments